BioCryst Pharmaceuticals Inc - Company & Market Research Reports

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.


Influenza A Viral Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Influenza A Viral Infections Drug Development Pipeline Review, 2018

  • Report
  • 188 Pages
From
Swine and Avian Influenza Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Swine and Avian Influenza Drug Development Pipeline Review, 2017

  • Report
  • 119 Pages
From
Hereditary Angioedema - Market Insights, Epidemiology and Market Forecast - 2025 - Product Thumbnail Image

Hereditary Angioedema - Market Insights, Epidemiology and Market Forecast - 2025

  • Drug Pipelines
  • 99 Pages
From
Global Influenza Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Influenza Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Hereditary Angioedema (HAE) Therapeutics - Pipeline Analysis 2017, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments - Product Thumbnail Image

Hereditary Angioedema (HAE) Therapeutics - Pipeline Analysis 2017, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

  • Report
  • 105 Pages
From
Infectious Disease Therapeutics Market Analysis by Disease Type (HIV infection, Influenza, Malaria, Tuberculosis, Hepatitis andHPV infection), by Region and Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Infectious Disease Therapeutics Market Analysis by Disease Type (HIV infection, Influenza, Malaria, Tuberculosis, Hepatitis andHPV infection), by Region and Segment Forecasts, 2014 - 2025

  • Report
  • 81 Pages
From
Infectious Disease Treatment Market in China 2016-2020 - Product Thumbnail Image

Infectious Disease Treatment Market in China 2016-2020

  • Report
  • 125 Pages
From
T-Cell Leukemia Global Clinical Trials Review, H2, 2016 - Product Thumbnail Image

T-Cell Leukemia Global Clinical Trials Review, H2, 2016

  • Clinical Trials
  • 173 Pages
From
Yellow Fever - Pipeline Review, H1 2018 - Product Thumbnail Image

Yellow Fever - Pipeline Review, H1 2018

  • Report
  • 49 Pages
From
Influenzavirus B Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Influenzavirus B Infections - Pipeline Review, H1 2018

  • Report
  • 129 Pages
From
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2018 - Product Thumbnail Image

Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2018

  • Report
  • 266 Pages
From
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H1 2018 - Product Thumbnail Image

Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H1 2018

  • Report
  • 71 Pages
From
Zika Virus Infections - Pipeline Review, H2 2017 - Product Thumbnail Image

Zika Virus Infections - Pipeline Review, H2 2017

  • Report
  • 183 Pages
From
Zika Virus Infections - Pipeline Review, H1 2017 - Product Thumbnail Image

Zika Virus Infections - Pipeline Review, H1 2017

  • Report
  • 177 Pages
From
Global Influenza Drugs and Vaccines Market - By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region, By Country - Product Thumbnail Image

Global Influenza Drugs and Vaccines Market - By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region, By Country

  • Report
  • 164 Pages
From
Marburg Hemorrhagic Fever - Pipeline Review, H2 2016 - Product Thumbnail Image

Marburg Hemorrhagic Fever - Pipeline Review, H2 2016

  • Report
  • 77 Pages
From
Yellow Fever - Pipeline Insight, 2018 - Product Thumbnail Image

Yellow Fever - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Global T-Cell Lymphoma Market & Clinical Pipeline Insight - Product Thumbnail Image

Global T-Cell Lymphoma Market & Clinical Pipeline Insight

  • Drug Pipelines
  • 168 Pages
From
Global Influenza Market - Vaccines and Therapeutics - Product Thumbnail Image

Global Influenza Market - Vaccines and Therapeutics

  • Report
  • 128 Pages
From
Ebola Viral Infections - Pipeline Review, H1 2016 - Product Thumbnail Image

Ebola Viral Infections - Pipeline Review, H1 2016

  • Report
  • 282 Pages
From
Loading Indicator
adroll